Qube Research & Technologies (QRT)’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
FIA
ACA
MSCM
ACM
IWS
Qube Research & Technologies (QRT)'s IHE Position: Q1 2026 in Review
Qube Research & Technologies (QRT) opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q1 2026: 378 shares worth $32.8K. The stake represents ﹤0.01% of the portfolio and ranks #3235 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in IHE as recently as Q1 2025.
Qube Research & Technologies (QRT) first reported a position in IHE in Q2 2021 and has held it in 15 quarters since. The position peaked at $257K in Q3 2022. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.
- Qube Research & Technologies (QRT) held 378 shares of iShares US Pharmaceuticals ETF worth $32.8K as of Q1 2026.
- iShares US Pharmaceuticals ETF was a new Qube Research & Technologies (QRT) position in Q1 2026.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3235 holding.
- Qube Research & Technologies (QRT) first reported a position in iShares US Pharmaceuticals ETF in Q2 2021 and has held it in 15 quarters since.
- Qube Research & Technologies (QRT)'s iShares US Pharmaceuticals ETF position peaked at $257K in Q3 2022.
- 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.